Tempus
AI-powered precision medicine platform that combines genomic testing, clinical data, and real-time intelligence to support oncology care decisions.
About
Tempus is a precision medicine company that has built one of the largest libraries of clinical and molecular data to help physicians make more informed treatment decisions, particularly in oncology. Its platforms include genomic sequencing and reporting, a clinical AI co-pilot for physicians, radiology image analysis, and real-world data tools for researchers and life sciences companies. The Next platform delivers real-time clinical intelligence to flag care gaps and guide therapy selection at the point of care. Tempus is a publicly traded company that works primarily with health systems, oncology practices, and pharmaceutical research teams; pricing is available through direct contact.